iver diseases in Lebano

• Conditions: liver diseases; fibrosis; K76.9

• Registration Number: LBCTR2020074524
• Lead Sponsor: PI initiated

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 470

Inclusion Criteria

all adults who presented for fibroscan at AUBMC hepatobiliary unit between 2016 and 2018

Exclusion Criteria

age less than 18

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ame: NAFLD percentage;Timepoints: at time of test ;Measure: number of patients;Name: alcoholic fatty liver;Timepoints: at time of test ;Measure: number of patients;Name: Hep A, B and C infections;Timepoints: at time of test;Measure: number of patients

Secondary Outcome Measures

Name	Time	Method
ame: risk factors associated with liver etiology;Timepoints: at time of test;Measure: number of patients